Crossmark

NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

Crossref DOI link: https://doi.org/10.1186/s41021-022-00244-3

Published Online: 2022-05-17

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Azadeh, Mansoureh

Salehzadeh, Ali http://orcid.org/0000-0003-4238-0999
Ghaedi, Kamran

Talesh Sasani, Soheila
License Information

Text and Data Mining valid from 2022-05-17

Version of Record valid from 2022-05-17
More Information

Article History

Received: 16 January 2022

Accepted: 1 April 2022

First Online: 17 May 2022

Declarations

:

: The protocol was authorized by the ethical committee of Islamic Azad Rasht Branch University (Bioethical code number: IR.IAU.RASHT.REC.1398.055).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below